Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Prehabilitation in Vulnerable Patients Undergoing Cystectomy for Bladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01840137
Recruitment Status : Completed
First Posted : April 25, 2013
Last Update Posted : August 8, 2019
Sponsor:
Information provided by (Responsible Party):
Jeffrey Montgomery, University of Michigan

Brief Summary:

The development of clinically relevant and scalable exercise interventions in older cystectomy patients may have an impact upon:

  • Patients: Exercise interventions may improve patient outcomes, including quality of life and avoidance of skilled nursing facilities.
  • Clinicians: Proving the safety and feasibility of targeted interventions in older surgical patients may facilitate the development of clinically relevant preoperative interventions suitable for wider study and implementation.
  • Payers: Improved surgical outcomes among high risk surgical patients will be associated with significant cost savings.
  • Researchers: Targeted and well controlled studies focusing on improving surgical outcomes through exercise may provide insight into relationships between patient factors, surgical stressors and outcomes. Ultimately, such work may lead to novel clinical approaches to optimize patients for surgery.

The investigators will study the effects of preoperative exercise training on cystectomy patients, specifically targeting increasing functional capacity and muscular strength. Prior to conducting a more extensive, multi-center, randomized-controlled trial, the feasibility, safety, and initial efficacy of preoperative exercise in cystectomy patients must be determined. To address this issue, the investigators will complete a trial of rehabilitation in cystectomy patients at the University of Michigan.


Condition or disease Intervention/treatment Phase
Bladder Cancer Other: Baseline Strength Test Other: Exercise Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 53 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Trial of Prehabilitation in Vulnerable Patients Undergoing Cystectomy for Bladder Cancer
Actual Study Start Date : June 2012
Actual Primary Completion Date : April 2018
Actual Study Completion Date : April 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Prehabilitation
The progressive, pre-operative exercise training program includes 3 supervised exercise sessions per week for 4 weeks. The first week of training will include an acclimation period accomplished via a ramping protocol. Subjects will warm-up on a treadmill for 5-minutes. Subjects will then complete 1 set of 15 repetitions exercising 8 major muscle groups during week one; during week #2 they will complete 2 sets with a goal of at least 12 repetitions; if subjects reach 15 repetitions on the second set, the resistance will be increased by 10% at the next training session to ensure progression. After completion of the resistance training portion of each session, subjects will walk on a treadmill for 30 minutes at a low/moderate intensity followed by a 5 minutes cool-down period.
Other: Baseline Strength Test
A symptom limited submaximal cardiopulmonary exercise test to estimate the subject's exercise capacity.

Other: Exercise
Treadmill and muscle exercises.




Primary Outcome Measures :
  1. Assess whether a pre-operative exercise training program (Prehabilitation) for elderly patients undergoing cystectomy for bladder cancer will lower their post-operative 90-day hospital readmission rate. [ Time Frame: 3 Years ]
    The study will compare the readmission rate of 70 recruited prehabilitation patients to the historic readmission rates from our institution and the published literature. Readmission will be defined as an admission to any acute care hospital after initial discharge from the immediate post-operative stay within 90 days of surgery. Visits to emergency rooms or urgent, unscheduled outpatient evaluations will be tracked, but will not count as a readmission. We will also track instances in which patients experience multiple re-admissions within 90 days of surgery, but for the purposes of this study, multiple re-admissions for an individual patient will only count as a single readmission event.


Secondary Outcome Measures :
  1. Determine the efficacy of prehabilitation on improving functional capacity and strength from baseline levels. [ Time Frame: 3 Years ]
    A submaximal exercise test and 6 minute walk test will be used to assess the maximal rate of oxygen utilization and functional capacity at baseline and at the conclusion of the intervention period. Muscular strength will be evaluated using volume loading.

  2. Composite of measures assessing the effects of prehabilitation on peri-operative cystectomy complications, resource utilization, patient reported outcomes, and functional status. [ Time Frame: 3 years ]
    Early (within 30 days of surgery) and late (between 31 and 90 days of surgery) complications, length of hospital stay, resource utilization (emergency room visits, need for sub-acute rehabilitation or nursing home stays, and the costs associated with this additional care) and post-operative outcomes, such as functional capacity and quality of life, will be evaluated and compared to historic data available in the published literature.

  3. Evaluate safety for a prehabilitation program in elderly cystectomy patients. [ Time Frame: 3 Years ]
    The endpoint for safety is the prevalence of adverse events during study-related assessments and exercise training sessions.

  4. Rates of attrition for a prehabilitation program in elderly cystectomy patients. [ Time Frame: 3 Years ]
    Study attrition will be the rate at which patients drop out of the study.

  5. Rates of adherence for a prehabilitation program in elderly cystectomy patients. [ Time Frame: 3 Years ]
    Study adherence will be the percentage of prescribed exercise sessions each participant completes during the treatment period.

  6. Rates of accrual for a prehabilitation program in elderly cystectomy patients. [ Time Frame: 3 Years ]
    Track the study recruitment rate and, once patients have been screened by the study team and approached to participate, note the reasons that patients who choose not to participate give for their refusal (personal preference, medical comorbidities/deconditioning, perceived program intensity, time commitment for the study protocol, travel distance or lack of consistent means of travel).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   60 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients must have biopsy-proven bladder cancer.
  • Patients age ≥60, diagnosed with bladder cancer with planned cystectomy and urinary diversion, +/- neoadjuvant chemotherapy.
  • The patient must be able to communicate and understand/complete forms/instructions, and be able to provide informed written consent prior to enrollment. Patients may have the assistance of an interpreter or surrogate when completing forms/surveys as needed.
  • Karnofsky performance status ≥70 with the ability to walk unassisted.
  • Sedentary baseline lifestyle, with an average of <180 minutes/week of moderate-intensity aerobic activity.
  • Attending surgeon clearance to undergo a supervised exercise training program.

Exclusion Criteria:

  • Contraindication to exercise training, such as skeletal metastases, symptomatic coronary artery disease, severe anemia, or any condition limiting their ability to participate in an exercise training program.
  • Patients who require surgery sooner than 28 days from enrollment.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01840137


Locations
Layout table for location information
United States, Michigan
University of Michigan
Ann Arbor, Michigan, United States, 48109
Sponsors and Collaborators
University of Michigan
Investigators
Layout table for investigator information
Principal Investigator: Jeffrey S. Montgomery, MD University of Michigan

Layout table for additonal information
Responsible Party: Jeffrey Montgomery, Associate Professor, Urology, University of Michigan
ClinicalTrials.gov Identifier: NCT01840137     History of Changes
Other Study ID Numbers: HUM00051581
First Posted: April 25, 2013    Key Record Dates
Last Update Posted: August 8, 2019
Last Verified: August 2019
Additional relevant MeSH terms:
Layout table for MeSH terms
Urinary Bladder Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Urinary Bladder Diseases
Urologic Diseases